Calculating the amount of plasmid DNA needed for a clinical trial may seem straightforward – simply multiply the dose by the number of doses to be administered. However, there are many factors to consider, and the required production scale may be several times the amount needed for clinical dosing. This white paper walks through one case study to illustrate… Read More »
GeneOne Life Science Receives Approval of IND by the Korean Ministry of Food and Drug Safety (KMFDS) of MERS-CoV Plasmid DNA vaccine, GLS-5300, for a Phase I/IIa Clinical Trial in Korea SEOUL, KOREA (PRWEB) September 17, 2017 GeneOne Life Science, Inc. announces that it has received approval from the South Korean Ministry of… Read More »
VGXI has reopened and we are getting back to normal operations. Our thoughts are with all those who have been affected by Hurricane Harvey, including our employees, their families, and all our neighbors in the area. For any who would like to contribute to the recovery effort, please consider a donation to… Read More »
Update: VGXI will open for business on Thursday, August 31, 2017. To ensure the safety of our employees and their families, VGXI closed from Monday through Wednesday, August 28th – 30th, 2017. Please stay safe and check back on our website or facebook page for updates.
Heading to Paris in October? Meet with representatives from VGXI and learn more about our products and services! We also welcome requests for partnering meetings during the conference. Contact Us today to make arrangements. 2017 International Society of Vaccines Annual Congress October 5 – 7, 2017 Institute Pasteur Paris, France
Come by Booth #1025 to meet us and find out more about VGXI’s products and services! We also welcome requests for partnering meetings during the conference. Biotechnology Industry Organization International Convention June 19-20, 2017 San Diego Convention Center San Diego, CA
Did you miss us at ASGCT? Download our poster at the link below: Novel Method for RNA Quantification and Exclusion from Plasmid DNA Vector Purification Process Stream Presented on Thursday, May 11, 2017 from 5:15 pm – 7:15 pm Session Information: Vector and Cell Engineering and Manufacturing Location: Exhibit Hall C & B… Read More »
VGXI will be attending the 2017 ASGTC Annual Meeting. Come view our poster presentation: Novel Method for RNA Quantification and Exclusion from Plasmid DNA Vector Purification Process Stream To be presented on Thursday, May 11, 2017 from 5:15 pm – 7:15 pm Session Information: Vector and Cell Engineering and Manufacturing Location: Exhibit Hall C… Read More »
VGXI announced that on April 10th, 2017 the corporation won the award for Best Production / Process Development at the 10th Annual ViE Awards Ceremony held at the 2017 World Vaccine Congress in Washington, D.C.
WVC is the ultimate meeting place for vaccine experts worldwide. 8 Conferences. 3 Days. 1 Event! April 10 – 12th, 2017 Grand Hyatt, Washington D.C. Join us and over 700 senior decision makers in Washington for three in-depth days of discussion and debate! WVC hosts over 150 sessions with leading experts speaking… Read More »
Votes are still being accepted for the shortlist of companies in each category! Show your support for VGXI by supporting us in the category of “Best Contract Manufacturing Organization” AND “Best Production/Process Development” for the Vaccine Industry Excellence Awards. Winners will be announced at the World Vaccine Congress in Washington DC in April, 2017. Follow… Read More »
IVI and GeneOne Life Science to collaborate in clinical development of GeneOne’s DNA-based MERS-CoV vaccine. The collaboration will accelerate vaccine development and ensure access for public health readiness in case of future outbreaks in Korea and worldwide. Signing ceremony for MERs-CoV vaccine development collaboration. The International Vaccine Institute (IVI) and GeneOne Life… Read More »
For more information